Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

The outbreak of coronavirus disease 2019 (COVID-19) has resulted in significant morbidity
and mortality worldwide. Vaccination against coronavirus disease 2019 is a useful weapon …

Methods We performed a longitudinal assessment in 48 patients with cirrhosis, 57 patients
with chronic hepatitis B (CHB) and 68 healthy controls (HCs) to continuously track the …

Background: We aimed to investigate the effect of non-alcoholic fatty liver disease (NAFLD)
on BNT162b2 immunogenicity against wild-type SARS-CoV-2 and variants and infection …

Background SARS-CoV-2 vaccine responses that could harbor potential risks to chronic
liver diseased patients. Aims To assess immune response following Pfizer's SARS-CoV-2 …

The COVID-19 pandemic is the largest epidemic of the 21st century so far. Over 650 million
people have already been infected with the SARS-CoV-2 virus. One of the ways to stop this …

This PhD thesis approaches a topic of interest, with important social and economic
implications, ie, non-alcoholic fatty liver (NAFL) in patients with type 2 diabetes mellitus …

UNIVERSITATEA DE MEDICINĂ ȘI FARMACIE “CAROL DAVILA”, BUCUREȘTI ȘCOALA
DOCTORALĂ MEDICINĂ GENERALĂ GASTROENTEROLOGIE Page 1 UNIVERSITATEA …

Introduction: Three years after the beginning of the SARS-CoV-2 pandemic, the safety and
efficacy of COVID-19 vaccination in liver cirrhosis (LC) patients remain controversial. We …